LCP
IDXX icon

LGT Capital Partners’s Idexx Laboratories IDXX Stock Holding History

LGT Capital Partners’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.7M Sell
79,135
-28,881
-27% -$16.2M 2.11% 17
2026
Q1 		$60.7M Buy
108,016
+2,018
+2% +$1.29M 3.22% 11
2025
Q4 		$71.7M Sell
105,998
-14,327
-12% -$9.76M 3.56% 9
2025
Q3 		$76.9M Sell
120,325
-29,246
-20% -$17.8M 3.73% 8
2025
Q2 		$80.2M Sell
149,571
-5,567
-4% -$2.66M 3.55% 8
2025
Q1 		$65.2M Buy
155,138
+11,840
+8% +$5.14M 2.89% 12
2024
Q4 		$59.2M Buy
143,298
+4,823
+3% +$2.12M 2.25% 16
2024
Q3 		$70M Sell
138,475
-17,090
-11% -$8.3M 2.43% 15
2024
Q2 		$75.8M Sell
155,565
-13,754
-8% -$6.9M 2.58% 13
2024
Q1 		$91.4M Sell
169,319
-24,450
-13% -$13.4M 2.86% 11
2023
Q4 		$108M Sell
193,769
-13,350
-6% -$6.27M 3.21% 11
2023
Q3 		$90.6M Sell
207,119
-1,990
-1% -$992K 3.26% 11
2023
Q2 		$105M Sell
209,109
-87,280
-29% -$41.8M 3.63% 9
2023
Q1 		$148M Sell
296,389
-19,726
-6% -$9.44M 4.13% 7
2022
Q4 		$129M Sell
316,115
-26,566
-8% -$10.3M 3.77% 8
2022
Q3 		$112M Buy
342,681
+59,721
+21% +$21.9M 3.41% 9
2022
Q2 		$99.2M Buy
282,960
+93,380
+49% +$38.1M 3.02% 11
2022
Q1 		$104M Buy
189,580
+57,410
+43% +$30.2M 2.95% 11
2021
Q4 		$87M Buy
132,170
+36,890
+39% +$23.2M 2.31% 20
2021
Q3 		$59.3M Sell
95,280
-2,990
-3% -$2.01M 1.79% 23
2021
Q2 		$62.1M Buy
98,270
+18,380
+23% +$10.1M 1.76% 21
2021
Q1 		$39.1M Buy
79,890
+18,000
+29% +$9.02M 1.28% 25
2020
Q4 		$30.9M Buy
61,890
+3,840
+7% +$1.72M 1.07% 27
2020
Q3 		$22.8M Sell
58,050
-8,040
-12% -$2.97M 0.96% 27
2020
Q2 		$21.8M Buy
66,090
+5,690
+9% +$1.65M 1.08% 27
2020
Q1 		$14.6M Buy
+60,400
New +$15.8M 0.94% 29

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

LGT Capital Partners's IDXX Position: Q2 2026 in Review

LGT Capital Partners reduced its Idexx Laboratories (IDXX) stake by 27% in Q2 2026, selling an estimated $16.2M and leaving 79,135 shares worth $41.7M. The position accounts for 2.11% of the portfolio, ranked #17.

LGT Capital Partners first reported a position in IDXX in Q1 2020 and has held it in 26 quarters since. The position peaked at $148M in Q1 2023. 1,300 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • LGT Capital Partners held 79,135 shares of Idexx Laboratories worth $41.7M as of Q2 2026.
  • LGT Capital Partners sold 28,881 Idexx Laboratories shares in Q2 2026, an estimated $16.2M.
  • Idexx Laboratories made up 2.11% of LGT Capital Partners's portfolio in Q2 2026, its #17 holding.
  • LGT Capital Partners first reported a position in Idexx Laboratories in Q1 2020 and has held it in 26 quarters since.
  • LGT Capital Partners's Idexx Laboratories position peaked at $148M in Q1 2023.
  • 1,300 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on LGT Capital Partners's 13F filing for Q2 2026, filed 5 Aug 2026.